{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:22:11Z","timestamp":1788315731972,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.brainresbull.2010.11.014","type":"journal-article","created":{"date-parts":[[2010,12,5]],"date-time":"2010-12-05T04:15:00Z","timestamp":1291522500000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus"],"prefix":"10.1016","volume":"84","author":[{"given":"Ayg\u00fcn","family":"Ertu\u011frul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atay","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgay","family":"Dalkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esen","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2010.11.014_bib0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration","volume":"60","author":"Angelucci","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.mp.4001637","article-title":"BDNF in schizophrenia, depression and corresponding animal models","volume":"10","author":"Angelucci","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of BDNF m RNA in rat hippocampus after treatmnet with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2008.03.023","article-title":"Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments","volume":"1211","author":"Balu","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vascn.2006.04.001","article-title":"The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity","volume":"54","author":"Bertaina-Anglade","year":"2006","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0030","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nprot.2006.205","article-title":"Object recognition in rats and mice: a one trial none-matching to sample learning task to study recognition memory","volume":"1","author":"Bevins","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/sj.bjp.0707509","article-title":"Role of the brain derived neurotrophic factor at glutamatergic synapses","volume":"153","author":"Carvalho","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/exnr.1993.1124","article-title":"Differential effects of MK-801 on BDNF mRNA levels in different regions of the rat brain","volume":"122","author":"Castren","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(02)03215-8","article-title":"Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration","volume":"954","author":"Chlan-Fourney","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2004.07.009","article-title":"Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism","volume":"1023","author":"Chung","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbr.2004.05.016","article-title":"Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats","volume":"156","author":"de Lima","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","article-title":"The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents","volume":"31","author":"Dere","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2006.05.021","article-title":"Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment","volume":"542","author":"Didriksen","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.brainresbull.2009.03.009","article-title":"Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies","volume":"79","author":"Drzyga","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0920-9964(00)00084-0","article-title":"Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses","volume":"52","author":"Durany","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A novel one-trial test for neurobiological studies of memory in rats. 1. Behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbr.2007.08.012","article-title":"Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats","volume":"186","author":"Enomoto","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0169-328X(99)00048-0","article-title":"Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine","volume":"67","author":"French","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0095","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jnr.10609","article-title":"Effect of antipsychotic drugs on BDNF expression under reduced NMDA receptor activity","volume":"72","author":"Fumagalli","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0100","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00001756-200409150-00022","article-title":"Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801","volume":"15","author":"Fumagalli","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","article-title":"Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat","volume":"184","author":"Grayson","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics","volume":"41","author":"Grillo","year":"2007","journal-title":"J. Psychiat. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00001756-199311180-00007","article-title":"Activation of NMDA receptors increases brain-derived neurotrophic factor (Bdnf) messenger-rna expression in the hippocampal-formation","volume":"5","author":"Gwag","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0006-3223(93)90043-D","article-title":"Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine","volume":"34","author":"Hagger","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent sub-chronic administration of clozapine, but not haloperidol","volume":"519","author":"Hashimoto","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biopsych.2006.05.016","article-title":"Fine tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine","volume":"61","author":"Homayoun","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0135","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0006-8993(02)02544-1","article-title":"5-HT1A and 5-HT2A receptors minimally contribute to clozapine induced acetylcholine release in rat medial prefrontal cortex","volume":"939","author":"Ichikawa","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0145","first-page":"15","article-title":"The ability of antipsychotics to prevent a sub-chronic pcp-induced cognitive deficit in the novel object recognition task in the rat","volume":"67","author":"Idris","year":"2005","journal-title":"Soc. Neurosci. Abstracts"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2006.06.046","article-title":"Valproate prevents MK-801 induced changes in brain-derived neurotrophic factor mRNA in the rat brain","volume":"545","author":"Jeon","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0155","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0160","doi-asserted-by":"crossref","unstructured":"J.T. Kantrowitz, D.C. Javitt, N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull., 2010, doi:10.1016\/j.brainresbull.2010.04.006.","DOI":"10.1016\/j.brainresbull.2010.04.006"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2007.07.033","article-title":"D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats","volume":"186","author":"Karasawa","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive Working Group. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2003.08.078","article-title":"Spatial learning is delayed and brain-derived neurotrophic factor mRNA expression inhibited by administration of MK-801 in rats","volume":"353","author":"Kesslak","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0180","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1460-9568.1994.tb00312.x","article-title":"Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus","volume":"6","author":"Knipper","year":"1994","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0185","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.npp.1300768","article-title":"N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors","volume":"30","author":"Li","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/JMN:14:1-2:027","article-title":"Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents","volume":"14","author":"Linden","year":"2000","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0195","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/neu.480251105","article-title":"Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain \u2013 implications for neuronal plasticity","volume":"25","author":"Lindholm","year":"1994","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1460-9568.2001.01633.x","article-title":"BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipschotic drugs","volume":"14","author":"Lipska","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0210","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0893-133X(00)00246-3","article-title":"Effects of age and gender on the expression of brain derived neurotrophic factor mRNA in rat retrosplenial cortex following administation of dizocilpine","volume":"25","author":"Matsuki","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0215","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"CATIE investigators, effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0220","unstructured":"K. McFarland, R.W. Johnson, T. Son, L. Pounds, K.E. Vanover, S. Bradley, et al., N-desmethlyclozapine demonstrated pro-cognitive actions in experimental models, International Congress on Schizophrenia Research 2007, Colorado Springs, CO."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0225","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.npp.1301188","article-title":"a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia","volume":"32","author":"Pichat","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0240","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/JCP.0b013e3181e69060","article-title":"Clozapine and global cognition in schizophrenia","volume":"30","author":"Rajji","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0245","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuropharm.2006.02.005","article-title":"Opposing effects of AMPA and 5 HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus","volume":"50","author":"Schiapparelli","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.schres.2004.06.015","article-title":"Impairing effects of chronic haloperidol and clozapine treatment on recognition memory: possible relation to oxidative stres","volume":"73","author":"Schr\u00f6der","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1369-1600.2006.00023.x","article-title":"Different effects of chronic phencyclidine on brain-derived neurotrophic factor in neonatal and adult rat brains","volume":"11","author":"Semba","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euroneuro.2004.12.005","article-title":"The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia","volume":"15","author":"Shoval","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02245612","article-title":"Differential effect of antipsychotics on place navigation of rats in the Morris water maze","volume":"124","author":"Skarsfeldt","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0270","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1124\/jpet.109.156349","article-title":"Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist","volume":"332","author":"Snigdha","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0275","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuropharm.2006.07.024","article-title":"CP-809, 101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity","volume":"52","author":"Siuciak","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0280","doi-asserted-by":"crossref","first-page":"13674","DOI":"10.1073\/pnas.1835612100","article-title":"N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates NMDA receptor activity","volume":"100","author":"Sur","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0920-9964(02)00505-4","article-title":"The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia","volume":"65","author":"Szekeres","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.02.054","article-title":"Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics","volume":"382","author":"Tan","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0295","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0269881105057002","article-title":"The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review","volume":"20","author":"Thornton","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-1781(02)00127-0","article-title":"Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients","volume":"110","author":"Toyooka","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0305","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11011-008-9083-8","article-title":"Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats","volume":"23","author":"Valvassori","year":"2008","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0320","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0325","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.schres.2006.08.021","article-title":"A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects","volume":"89","author":"Woodward","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0330","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.pnpbp.2009.08.011","article-title":"Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics","volume":"33","author":"Xiu","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0335","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0024-3205(01)01461-8","article-title":"Role for brain derived neurotrophic factor in learning and memory","volume":"70","author":"Yamada","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2010.11.014_bib0340","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2009.02.004","article-title":"Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia","volume":"122","author":"Young","year":"2009","journal-title":"Pharmacol. Ther."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923010002728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923010002728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:09:18Z","timestamp":1759781358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923010002728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0361923010002728"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2010.11.014","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2010.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}